Your browser doesn't support javascript.
loading
Using the algorithm of the Fetal Medicine Foundation to determine the cutoff point for prediction of pre-eclampsia in a Brazilian population.
Andrade, Joana A; Viana Junior, Antonio B; Holanda Moura, Sammya B; Gurgel Alves, Julio A; Araujo Júnior, Edward; Carvalho, Francisco H.
Affiliation
  • Andrade JA; Department of Women's, Child and Adolescent Health, Assis Chateaubriand Maternity School, Federal University of Ceará (UFC), Fortaleza, Brazil.
  • Viana Junior AB; Department of Women's, Child and Adolescent Health, Assis Chateaubriand Maternity School, Federal University of Ceará (UFC), Fortaleza, Brazil.
  • Holanda Moura SB; University of Fortaleza (UNIFOR), Fortaleza, Brazil.
  • Gurgel Alves JA; Department of Women's, Child and Adolescent Health, Assis Chateaubriand Maternity School, Federal University of Ceará (UFC), Fortaleza, Brazil.
  • Araujo Júnior E; University of Fortaleza (UNIFOR), Fortaleza, Brazil.
  • Carvalho FH; Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo, Brazil - araujojred@terra.com.br.
Minerva Obstet Gynecol ; 75(6): 503-511, 2023 Dec.
Article de En | MEDLINE | ID: mdl-35758093
ABSTRACT

BACKGROUND:

To use the algorithm of the Fetal Medicine Foundation (FMF) to determine the cutoff point for prediction of preeclampsia (PE) in a Brazilian population.

METHODS:

Randomized clinical trial with 274 nulliparous patients at gestational age between 11 and 13 weeks and 6 days. To calculate the risk of PE, the algorithm available at the website of the FMF (http//fetalmedicine.org/research/assess/preeclampsia/first-trimester) was used. Among the patients, 138 did not use preventive measures (100 mg/day aspirin [ASA]). Youden's criteria were used to calculate the cutoff point. To test the effectiveness of 100 mg/day ASA in preventing PE, the patients were divided into two groups - at risk above and below the cutoff point.

RESULTS:

In the group comprising the 135 patients that did not take ASA, the median age was 22 years, the Body Mass Index (BMI) was 59.3 kg/m2, the mean arterial pressure (MAP) was 73.3 mmHg, and the mean pulsatility index of uterine artery Doppler was 1.71. The median gestational age at delivery was 39.3 (38.1-40.3) weeks. The prevalence of PE was 11.1%. In our sample, the use of 100 mg/day ASA reduced total PE by 36.3% (prevalence of PE in the group above the cutoff point was 19% and 12.1% when ASA and placebo were used, respectively).

CONCLUSIONS:

The cutoff point defined for prediction of PE was 1155 with sensitivity of 80%, specificity of 57.5%, positive predictive value of 19.1%, and negative predictive value of 95%, which should help to select patients that will benefit from prophylactic ASA.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pré-éclampsie Type d'étude: Clinical_trials / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Pregnancy Pays/Région comme sujet: America do sul / Brasil Langue: En Journal: Minerva Obstet Gynecol Année: 2023 Type de document: Article Pays d'affiliation: Brésil

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pré-éclampsie Type d'étude: Clinical_trials / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Pregnancy Pays/Région comme sujet: America do sul / Brasil Langue: En Journal: Minerva Obstet Gynecol Année: 2023 Type de document: Article Pays d'affiliation: Brésil